An amendment to provide for transparency in the relationship between physicians and applicable manufacturers with respect to payments and other transfers of value and physician ownership or investment interests in manufacturers.
Requires any manufacturer of a covered drug, device, biological, or medical supply that makes a payment or another transfer of value to a physician, a physician medical practice, or a physician group practice to report annually, in electronic form, specified information on such transactions to the Secretary of Health and Human Services.
Requires any such manufacturer, or related group purchasing organization, also to report annually to the Secretary, in electronic form, certain information regarding any ownership or investment interest (other than in a publicly traded security and mutual fund) held by a physician (or an immediate family member) in the manufacturer or group purchasing organization during the preceding year.
Prescribes administrative penalties for failure to comply with these requirements.
Requires report submission procedures to ensure public availability of required information on a website.
Participating counts on VoteMatch question 5.
Question 5: More federal funding for health coverage
Scores: -2=Strongly oppose; -1=Oppose; 0=neutral; 1=Support; 2=Strongly support.
Topic: Health Care
Headline: Disclose payments from manufacturers to physicians
Headline 2: Sponsored bill to disclose pharma payments to physicians